1 ( Translation ) Ref. NEP146-2017 October 25, 2017 Subject : Resolutions of the Board of Directors approving the capital decrease, the capital increase, the allotment of newly issued ordinary shares

subsidiary for Quarter 1 of 2018 ending on 31 March 2018 as follows; Statements of Comprehensive Income Revenue from Hospital Operations The Company generated the revenue from hospital operations for the 1st

and its subsidiary for the fiscal year ended on December 31, 2018 as follows; Statements of Comprehensive Income Revenues from medical treatment The Company generated the revenues from medical treatment

comprehensive income showed operating results 105.49 million baht when compared to the previous year. The net profit grew by 35.99 million baht or 51.8%, which is a change of more than 20%. The Company's sales

ended 30 June % changes 2019 2018 Increase (decrease) Sales 134,591 179,969 (25.21) Total revenues 333,590 195,327 70.79 Cost of sales 152,878 172,470 (11.36) Selling and administrative expenses 18,982

countries. The Company’s gross profit demonstrated at 33.8% to sale value, declined from same quarter last year reported at 37.2% due to the increase in energy prices and Thai Baht appreciation against US

and its subsidiary for Quarter 2 of 2018 ending on 30 June 2018 as follows; Statements of Comprehensive Income Revenue from Hospital Operations The Company generated the revenue from hospital operations

its subsidiaries for the ended 31 December 2017 represented a loss of Baht 2,156.49 million. Compared to the same period of 2016, the loss was Baht 1,179.47 million (restated), an increase loss of 83

Company and its subsidiary for Quarter 3 of 2018 ending on 30 September 2018 as follows; Statements of Comprehensive Income Revenue from Hospital Operations The Company generated the revenue from hospital

the explanation and analysis of the Management for the 2nd quarter of 2020 ended 30 June 2020 as follows. 1. Income, gross profit, net profit Unit : Million Baht 1. Income 2020 2019 2018 Increase